Diagnosis and treatment of lung cancer: Summary of updated NICE guidance

BMJ

Volumn 342, Issue 7805, 2011, Pages

  Baldwin, D R ^a   White, B ^a   Schmidt Hansen, M ^b   Champion, A R ^b   Melder, A M ^c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b National Collaborating Centre for Cancer   (United Kingdom)

^c Centre for Clinical Effectiveness   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; HUMAN; LOBECTOMY; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; NATIONAL HEALTH ORGANIZATION; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TRANSBRONCHIAL ASPIRATION; WEDGE RESECTION;

AIRWAY OBSTRUCTION; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION;

EID: 80052490215     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2110     Document Type: Review

References (10)

1. Cancer research UK. Cancer mortality - UK statistics. http://info.cancerresearchuk.org/cancerstats/mortality/.
2. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK (the International Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127-38.
3. NHS Information Centre. National lung cancer audit 2009. IC23090809. www.ic.nhs.uk/webfiles/Services/NCASP/audits%20and%20reports/ NHS%20IC%20Lung%20Cancer%20AUDIT%202009%20FINAL.pdf.
4. National Institute for Health and Clinical Excellence. The diagnosis and treatment of lung cancer (update). (Clinical guideline 121) 2011. http://guidance.nice.org.uk/CG121.
5. Falcoz PE, Conti M, Brouchet L, Chocron S, Puyraveau M, Mercier M, et al. The thoracic surgery scoring system (Thoracoscore): risk model for in-hospital death in 15,183 patients requiring thoracic surgery. J Thorac Cardiovasc Surg 2007;133:325-32. (Pubitemid 46136251)
6. National Institute for Health and Clinical Excellence. Erlotinib for the treatment of non-small-cell lung cancer. (Technology appraisal 162.) 2008. www.nice.org.uk/ta162.
7. National Institute for Health and Clinical Excellence. Pemetrexed for the first-line treatment of non-small-cell lung cancer. (Technology appraisal 181.) 2009. www.nice.org.uk/ta181.
8. National Institute for Health and Clinical Excellence. Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer. (Technology appraisal 192.) 2010. www.nice.org.uk/ta192.
9. National Institute for Health and Clinical Excellence. Topotecan for the treatment of relapsed small-cell lung cancer. (Technology appraisal 184.) 2009. www.nice.org.uk/ta184.
10. National Institute for Health and Clinical Excellence. Guidelines manual. 2009. www.nice.org.uk/media/5F2/44/The-guidelines-manual-2009---All-chapters. pdf.